In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PRILOCAINE BASE Drug Master File in Korea (PRILOCAINE BASE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PRILOCAINE BASE. The MFDS reviews the PRILOCAINE BASE KDMF as part of the drug registration process and uses the information provided in the PRILOCAINE BASE KDMF to evaluate the safety and efficacy of the drug.
After submitting a PRILOCAINE BASE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PRILOCAINE BASE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PRILOCAINE BASE suppliers with KDMF on PharmaCompass.